Literature DB >> 33306449

SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.

Hannah J Riley1, Ryan R Kelly2,3, An O Van Laer1, Lily S Neff1, Shaoni Dasgupta1, Catalin F Baicu1, Lindsay T McDonald2,3, Amanda C LaRue2,3, Michael R Zile1,3, Amy D Bradshaw1,3.   

Abstract

In human heart failure and in murine hearts with left-ventricular pressure overload (LVPO), increases in fibrosis are associated with increases in myocardial stiffness. Secreted protein acidic and rich in cysteine (SPARC) is shown to be necessary for both cardiac fibrosis and increases in myocardial stiffness in response to LVPO; however, cellular sources of cardiac SPARC are incompletely defined. Irradiation and bone marrow transfer were undertaken to test the hypothesis that SPARC expression by bone marrow-derived cells is an important mediator of fibrosis in LVPO. In recipient SPARC-null mice transplanted with donor wild-type (WT) bone marrow and subjected to LVPO, levels of fibrosis similar to that of WT mice were found despite the lack of SPARC expression by resident cells. In recipient WT mice with donor SPARC-null bone marrow, significantly less fibrosis versus that of WT mice was found despite the expression of SPARC by resident cells. Increases in myocardial stiffness followed a similar pattern to that of collagen deposition. Myocardial macrophages were significantly reduced in SPARC-null mice with LVPO versus that of WT mice. Recipient SPARC-null mice transplanted with donor WT bone marrow exhibited an increase in cardiac macrophages versus that of SPARC-null LVPO and donor WT mice with recipient SPARC-null bone marrow. Expression of vascular cellular adhesion molecule (VCAM), a previously identified binding partner of SPARC, was assessed in all groups and with the exception of WT mice, increases in VCAM immunoreactivity with LVPO were observed. However, no differences in VCAM expression between bone marrow transplant groups were noted. In conclusion, SPARC expression by bone marrow-derived cells was critical for fibrotic deposition of collagen and influenced the expansion of myocardial macrophages in response to LVPO.NEW & NOTEWORTHY Myocardial fibrosis and the resultant increases in LV and myocardial stiffness represent pivotal consequences of chronic pressure overload (PO). In this study, a murine model of cardiac fibrosis induced by PO was used to demonstrate a critical function of SPARC in bone marrow-derived cells that drives cardiac fibrosis and increases in cardiac macrophages.

Entities:  

Keywords:  collagen; extracellular matrix; heart; inflammation; macrophage; matricellular

Mesh:

Substances:

Year:  2020        PMID: 33306449      PMCID: PMC8082795          DOI: 10.1152/ajpheart.00552.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

1.  SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration.

Authors:  Kimberly A Kelly; Jennifer R Allport; Amy M Yu; Sumita Sinh; E Helene Sage; Robert E Gerszten; Ralph Weissleder
Journal:  J Leukoc Biol       Date:  2006-12-18       Impact factor: 4.962

Review 2.  Inflammation and fibrosis in murine models of heart failure.

Authors:  Lucas Bacmeister; Michael Schwarzl; Svenja Warnke; Bastian Stoffers; Stefan Blankenberg; Dirk Westermann; Diana Lindner
Journal:  Basic Res Cardiol       Date:  2019-03-18       Impact factor: 17.165

3.  Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis.

Authors:  Lindsay T McDonald; Michael R Zile; Yuhua Zhang; An O Van Laer; Catalin F Baicu; Robert E Stroud; Jeffrey A Jones; Amanda C LaRue; Amy D Bradshaw
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-09       Impact factor: 4.733

Review 4.  Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry.

Authors:  William H Gaasch; Michael R Zile
Journal:  J Am Coll Cardiol       Date:  2011-10-18       Impact factor: 24.094

5.  Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Authors:  Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; D Dirk Bonnema; Michael R Zile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

6.  Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload.

Authors:  Ying Xia; Keunsang Lee; Na Li; Daniel Corbett; Leonardo Mendoza; Nikolaos G Frangogiannis
Journal:  Histochem Cell Biol       Date:  2008-11-22       Impact factor: 4.304

Review 7.  The role of secreted protein acidic and rich in cysteine (SPARC) in cardiac repair and fibrosis: Does expression of SPARC by macrophages influence outcomes?

Authors:  Amy D Bradshaw
Journal:  J Mol Cell Cardiol       Date:  2015-11-12       Impact factor: 5.000

8.  MCP1 directs trafficking of hematopoietic stem cell-derived fibroblast precursors in solid tumor.

Authors:  Romeo S Abangan; Christopher R Williams; Meenal Mehrotra; James D Duncan; Amanda C Larue
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

9.  The role of SPARC in extracellular matrix assembly.

Authors:  Amy D Bradshaw
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

10.  Cardiac macrophages promote diastolic dysfunction.

Authors:  Maarten Hulsmans; Hendrik B Sager; Jason D Roh; María Valero-Muñoz; Nicholas E Houstis; Yoshiko Iwamoto; Yuan Sun; Richard M Wilson; Gregory Wojtkiewicz; Benoit Tricot; Michael T Osborne; Judy Hung; Claudio Vinegoni; Kamila Naxerova; David E Sosnovik; Michael R Zile; Amy D Bradshaw; Ronglih Liao; Ahmed Tawakol; Ralph Weissleder; Anthony Rosenzweig; Filip K Swirski; Flora Sam; Matthias Nahrendorf
Journal:  J Exp Med       Date:  2018-01-16       Impact factor: 14.307

View more
  7 in total

1.  Secreted Protein Acidic and Rich in Cysteine Mediates the Development and Progression of Diabetic Retinopathy.

Authors:  Liying Luo; Xi Sun; Min Tang; Jiahui Wu; Tianwei Qian; Shimei Chen; Zhiyuan Guan; Yanyun Jiang; Yang Fu; Zhi Zheng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

Review 2.  From Systemic Inflammation to Myocardial Fibrosis: The Heart Failure With Preserved Ejection Fraction Paradigm Revisited.

Authors:  Walter J Paulus; Michael R Zile
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

3.  Secreted Protein Acidic and Rich in Cysteine as A Regeneration Factor: Beyond the Tissue Repair.

Authors:  Abdelaziz Ghanemi; Mayumi Yoshioka; Jonny St-Amand
Journal:  Life (Basel)       Date:  2021-01-08

4.  Titanium Nanoparticles Enhance Production and Suppress Stabilin-1-Mediated Clearance of GDF-15 in Human Primary Macrophages.

Authors:  Lina S Silva-Bermudez; Tatyana N Sevastyanova; Christina Schmuttermaier; Carolina De La Torre; Leonie Schumacher; Harald Klüter; Julia Kzhyshkowska
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

5.  Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.

Authors:  Yuhua Zhang; An O Van Laer; Catalin F Baicu; Lily S Neff; Stanley Hoffman; Marc R Katz; Sanford M Zeigler; Michael R Zile; Amy D Bradshaw
Journal:  PLoS One       Date:  2022-01-11       Impact factor: 3.240

Review 6.  The Role of Matrix Proteins in Cardiac Pathology.

Authors:  Katie Trinh; Sohel M Julovi; Natasha M Rogers
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

7.  β-catenin cancer-enhancing genomic regions axis is involved in the development of fibrolamellar hepatocellular carcinoma.

Authors:  Ruhi Gulati; Michael Johnston; Maria Rivas; Ashley Cast; Meenasri Kumbaji; Margaret A Hanlon; Sanghoon Lee; Ping Zhou; Charissa Lake; Emily Schepers; Kyung-Won Min; Je-Hyun Yoon; Rebekah Karns; Lola M Reid; Dolores Lopez-Terrada; Lubov Timchenko; Sreeja Parameswaran; Matthew T Weirauch; Sarangarajan Ranganathan; Alexander Bondoc; James Geller; Gregory Tiao; Soona Shin; Nikolai Timchenko
Journal:  Hepatol Commun       Date:  2022-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.